![[HTML version]](/c/graphics/htmlborder.gif)
![[PDF version]](/c/graphics/pdfborder.gif)
![[CIF]](/c/graphics/cifborder.gif)
![[3d view]](/c/graphics/3dviewborder.gif)
![[Structure Factors]](/c/graphics/structurefactorsborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](sk1544contents.gif)
Acta Cryst. (2002). C58, o362-o364 [ doi:10.1107/S0108270102006443 ]
(1R)-2-[(3R,4S)-3-Methyl-4-(N-phenyl-N-propionylamino)piperidin-1-yl]-1-phenylethyl p-bromobenzoate and N-{(3R,4S)-1-[(2S)-2-(4-bromophenyl)-2-hydroxyethyl]-3-methyl-piperidin-4-yl}-N-phenylacrylamide
J. R. Deschamps, C. George and J. L. Flippen-Anderson
Formula: C30H33BrN2O3 and C23H27BrN2O2
Online 31 May 2002
Copyright © International Union of Crystallography
IUCr Webmaster